[Recent acquisitions in the treatment of arrhythmias].
D000200:Action Potentials / Q000187:drug effects; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009467:Neuromuscular Depolarizing Agents / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D009125:Muscle Relaxants, Central; D009467:Neuromuscular Depolarizing Agents; D013565:Sympatholytics; D014665:Vasodilator Agents; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D007545:Isoproterenol
Acquisitions récentes dans le traitement des arythmies.